Equities

Pontus Protein Ltd

HULK.H:NEX

Pontus Protein Ltd

Actions
  • Price (CAD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Jun 05 2023.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pontus Protein Ltd. is a Canada-based agricultural food and technology company focused on creating and acquiring technology. The Company has artificial intelligence (AI)-engineered robots, combined with its proprietary vertical farming. The Company delivers foods and nutrients to every diet in a closed, controlled environment, avoiding all pesticides and genetically modified organisms (GMOs). The Company is focused on production of organic plant-based protein products. It specializes in aquaponic farming through the employment of its closed environment vertical aquaponics system (CEVAS), a network of automated bio-secure indoor aquaponic farms utilizing AI, to produce a non-GMO, organic plant-based protein product called Pontus Protein Powder. Pontus Protein Powder is designed to be added to enhance the nutrition profile of food and drinks, at home or for food producers. Its water lentils are grown without the use of solvents, chemicals, dyes, additives, preservatives, or pesticides.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-9.13m
  • Incorporated2018
  • Employees--
  • Location
    Pontus Protein Ltd17686 - 66A AvenueSURREY V3S 2A7CanadaCAN
  • Phone+1 (778) 999-3353
  • Fax+1 (604) 837-7990
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Many Bright Ideas Technologies Inc0.00-77.91k382.87k-----------0.0045-0.00450.00-0.01060.00-------402.83-267.91------------------------7.85------
biOasis Technologies Inc269.38k-2.88m398.56k--------1.48-0.0376-0.03760.0036-0.0340.113--7.24---120.62-170.20---2,618.50-----1,067.57-224.22---------99.07-40.66-523.83------
Pontus Protein Ltd0.00-9.13m488.26k----0.2214-----0.1577-0.15770.000.02260.00-------126.32---160.86-------------14.160.5126--------------
Data as of Jun 05 2023. Currency figures normalised to Pontus Protein Ltd's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.